Lawyers at DLA Piper are defending Novo Nordisk in a product liability action involving the company's blockbuster weight loss drug Wegovy. The lawsuit, filed Sept. 19 by Motley Rice in Philadelphia County, claims that the drugmaker downplayed or failed to disclose known side effects of Wegovy, including gastroparesis, gastroenteritis, intestinal blockage and malnutrition. DLA Piper removed the matter to Pennsylvania Eastern District Court on Oct. 10. The case is 2:23-cv-0392, Miller v. Novo Nordisk et al.
Biotech & Pharmaceuticals
October 10, 2023, 4:40 PM